Transcat, Inc. (NASDAQ:TRNS) Receives $112.20 Consensus PT from Analysts

Shares of Transcat, Inc. (NASDAQ:TRNS) have received a consensus rating of “Moderate Buy” from the five ratings firms that are currently covering the company, MarketBeat.com reports. Two investment analysts have rated the stock with a hold recommendation and three have assigned a buy recommendation to the company. The average 1 year price objective among brokers that have covered the stock in the last year is $112.20.

TRNS has been the topic of a number of recent research reports. HC Wainwright reiterated a “buy” rating and set a $116.00 price target on shares of Transcat in a research note on Wednesday, June 25th. Lake Street Capital initiated coverage on shares of Transcat in a research note on Thursday, July 10th. They set a “buy” rating and a $105.00 price target on the stock. Finally, Wall Street Zen upgraded shares of Transcat from a “sell” rating to a “hold” rating in a research note on Wednesday, May 28th.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in TRNS. Quantbot Technologies LP acquired a new position in Transcat during the 1st quarter worth approximately $76,000. State of Wyoming acquired a new position in Transcat during the 1st quarter worth approximately $95,000. Morgan Dempsey Capital Management LLC boosted its position in Transcat by 41.7% during the 2nd quarter. Morgan Dempsey Capital Management LLC now owns 1,352 shares of the scientific and technical instruments company’s stock worth $116,000 after acquiring an additional 398 shares during the last quarter. Aquatic Capital Management LLC boosted its position in Transcat by 1,052.0% during the 4th quarter. Aquatic Capital Management LLC now owns 1,152 shares of the scientific and technical instruments company’s stock worth $122,000 after acquiring an additional 1,052 shares during the last quarter. Finally, GAMMA Investing LLC boosted its position in Transcat by 10,137.5% during the 1st quarter. GAMMA Investing LLC now owns 1,638 shares of the scientific and technical instruments company’s stock worth $122,000 after acquiring an additional 1,622 shares during the last quarter. 98.34% of the stock is owned by institutional investors.

Transcat Trading Up 3.0%

NASDAQ:TRNS opened at $77.92 on Monday. Transcat has a 12 month low of $67.56 and a 12 month high of $133.72. The firm has a market cap of $726.21 million, a price-to-earnings ratio of 49.95 and a beta of 0.71. The company has a quick ratio of 1.87, a current ratio of 2.29 and a debt-to-equity ratio of 0.11. The company’s 50 day moving average is $82.25 and its 200-day moving average is $81.22.

Transcat (NASDAQ:TRNS) last released its quarterly earnings results on Wednesday, August 6th. The scientific and technical instruments company reported $0.59 EPS for the quarter, beating analysts’ consensus estimates of $0.40 by $0.19. The company had revenue of $76.42 million for the quarter, compared to analyst estimates of $72.28 million. Transcat had a net margin of 5.21% and a return on equity of 6.47%. Equities analysts anticipate that Transcat will post 2.3 EPS for the current year.

Transcat Company Profile

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.